FOLH1 and posterior cortical atrophy: Its simple, efficient (> 50% none-decay-corrected) labeling at > 15 GBq levels, and desirable performance characteristics in PCa patients makes [18F]AlF-P16-093 an attractive alternative to existing PSMA-targeted tracers.